Integrated Quantitative Investments’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,200
Closed -$940K 411
2025
Q1
$940K Buy
11,200
+1,300
+13% +$121K 0.46% 81
2024
Q4
$912K Buy
+9,900
New +$952K 0.45% 90

Other funds holding LMAT

Integrated Quantitative Investments's LMAT Position: Q2 2025 in Review

Integrated Quantitative Investments sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 11,200 shares — an estimated $940K sold.

Integrated Quantitative Investments first reported a position in LMAT in Q4 2024 and held it in 2 quarters. The position peaked at $940K in Q1 2025. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

  • Integrated Quantitative Investments reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
  • Integrated Quantitative Investments sold 11,200 LeMaitre Vascular shares in Q2 2025, an estimated $940K.
  • Integrated Quantitative Investments first reported a position in LeMaitre Vascular in Q4 2024 and held it in 2 quarters.
  • Integrated Quantitative Investments's LeMaitre Vascular position peaked at $940K in Q1 2025.
  • 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Integrated Quantitative Investments's 13F filing for Q2 2025, filed 11 Aug 2025.